TruthArchive.ai - Related Video Feed

I found over 100 scientific papers showing Ivermectin's potential against cancer, primarily from preclinical studies. Researchers are puzzled by how this anti-parasitic drug, which has been effective for decades, can also treat cancer. Ivermectin is off patent, meaning there's little financial incentive for big pharma to invest in its research. Notably, Ivermectin can kill cancer stem cells, reverse chemotherapy resistance, and enhance the effectiveness of both chemotherapy and radiation. Patients combining Ivermectin with these treatments have shown remarkable results, including significant tumor reductions. After two years of research, I now treat over 1,000 cancer patients with Ivermectin and other anti-parasitic drugs. The recent mention by Mel Gibson about friends curing stage 4 cancer with these treatments highlights the growing awareness of this approach.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like Ivermectin, Fenbendazole, and methylene blue, which was originally a textile dye but has shown significant benefits for mitochondria. It's surprising to see effective treatments being overlooked, raising questions about the medical industry's priorities. Why are cures that aren't profitable often ignored or demonized? This situation highlights a failure in our medical institutions to promote genuinely effective solutions.

Fenbendazole is an overlooked cancer drug with at least 12 proven anti-cancer mechanisms. It disrupts microtubule polymerization, induces cell cycle arrest, blocks glucose transport, increases tumor suppressor levels, inhibits cancer cell viability, migration, and invasion, induces apoptosis, autophagy, and necrosis, and inhibits angiogenesis and drug resistance. Mebendazole, a similar drug, is already approved by the FDA and in clinical trials for brain and colon cancers. However, there are no Fenbendazole clinical trials for cancer, likely because it is cheap, safe, and effective. Big pharma may not see a profit margin in it, which raises concerns about their motives. This highlights the issue of a society designed to make people sick, with pharmaceutical companies profiting from remedies.

"We get sick because of three things primarily. We get sick because of electromagnetic radiation, because of poisons that they put into the environment, and because of parasites." "I found about about five or six years ago, underground group of people that were using Fenbendazole in these things for cancer, and it was working." "He had throat cancer." "So his wife searched around the internet and found this story about the Fenbendazole and started treating him using the protocol." "Isn't it interesting that parasitic medication also treats cancer?" "I think it's not that it also treats cancer, it's that cancer is parasites."

Speaker 1 states they haven't been encouraged to speak about a BioShield, as they are not a political person, but believe it holds a solution for both COVID and cancer. The speaker believes the two are completely connected. They claim the political deep state is powerful, vicious, and egotistical, to the point of stopping good science. The speaker is now speaking out because the drug is approved, but only for bladder cancer. They claim it has the same treatment effect for pancreatic cancer, lung cancer, and triple negative breast cancer. They state it is the only molecule for fifty years that upregulates killer cells.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like Ivermectin, Fenbendazole, and methylene blue, which was originally a fabric dye but is now known to have significant effects on mitochondria. It's surprising to discover that many effective treatments are overlooked or demonized, raising questions about the motives behind our medical institutions. Why are these cures not promoted when they are not profitable?

The speaker shares their personal experience with cancer and their journey to finding an alternative treatment. They discuss undergoing surgeries and years of chemotherapy before reaching their lifetime maximum. Feeling hopeless, they receive a suggestion to try a dewormer called fenbendazole. Skeptical at first, they decide to give it a try and start taking a combination of fenbendazole, curcumin, somatodine, annatto, and AHCC. To their surprise, subsequent scans show a reduction in the disease, and eventually, they become cancer-free. The speaker emphasizes the importance of faith and encourages others to explore alternative treatments. They also mention the financial interests of the pharmaceutical industry.

The speaker notes that certain parasite medications show strong potential in targeting glutamine metabolism in cancer. Specifically, the Benzazole class and Fenbendazole are highlighted as medications being explored in this context. The central question addressed is why a parasite medication might be effective against cancer cells. The answer given is that parasites and cancer cells share a common metabolic pathway: glutaminolysis. This pathway involves substrate-level phosphorylation in the mitochondria, and it is the same metabolic process being targeted. The speaker references a recent publication related to this mechanism, described as a paper with Derek’s big paper, indicating that the concept and supporting data have been recently published. The emphasis is on the idea that inhibiting glutaminolysis could disrupt a critical energy and biosynthetic pathway that both parasite-infected cells and cancer cells rely upon, potentially providing a therapeutic avenue. The discussion reinforces that the medications under consideration—Benzazole compounds and Fenbendazole—are being actively developed or tested for their ability to interfere with this shared mitochondrial metabolic route. Additionally, the speaker connects the effectiveness of these parasite drugs to the broader principle that targeting a common metabolic vulnerability in cancer cells may yield translational opportunities from antiparasitic strategies. The overall point is that leveraging parasite medicines, which may disrupt glutaminolysis, could offer a way to impair cancer cell metabolism through mitochondrial substrate-level phosphorylation, a mechanism now supported by recent publication activity. The takeaway is that there is ongoing work to validate the approach of repurposing parasite-targeting drugs to exploit the glutaminolysis pathway in cancer, with empirical support emerging from the referenced Derek-associated publication.

The speaker shares a personal story about their mother's experience with cancer and Fenbendazole. Initially skeptical, the mother eventually started taking Fenbendazole and saw positive results. The tumors in her body disappeared, impressing her doctors. However, when a new doctor learned about the Fenbendazole, he refused to treat her if she continued taking it. The mother stopped taking Fenbendazole and three months later, she passed away with a tumor in her brain. The speaker believes that Fenbendazole is effective and recommends it for cancer patients.

I have three friends who had stage 4 cancer, and now they’re cancer-free. They took Ivermectin, Fenbendazole, and Methylene Blue, which has surprising benefits for mitochondria. It’s concerning how effective treatments are often ignored for profit. I got COVID and received remdesivir, which caused severe issues, while a friend died. There’s a troubling trend of prioritizing profit over lives in healthcare. Monoclonal antibodies were restricted to promote vaccines, which raises ethical questions. Mel Gibson and others are starting to speak out against these issues, highlighting the dangers of certain treatments and the need for awareness. We must recognize the importance of sharing knowledge and supporting those who fight against these injustices.

A nurse's mother initially hesitated to take Fenbendazole for her cancer, dismissing it as a dog dewormer. However, after months of persuasion, she started the treatment and experienced remarkable results. The golf ball-sized tumors in her brain, lungs, liver, and kidneys disappeared, impressing her doctors. Unfortunately, when she informed her new doctor about the Fenbendazole, he refused to treat her if she continued taking it. She stopped the treatment and passed away three months later. A subsequent MRI revealed a tumor in her brain that had rapidly grown since she stopped taking Fenbendazole. The speaker believes that Fenbendazole is effective and recommends it for cancer patients.

I am presenting a case series of three patients whose cancers went into remission after taking the antiparasitic drug fenbendazole, as detailed in a paper published in Clinical Oncology Case Reports. Fenbendazole is a veterinary medicine that interferes with microtubule formation during cell division, which may inhibit cancer cell proliferation. This suggests it could be a safe and effective option for cancer treatment. There is an urgent need for drug regulators to consider repurposing fenbendazole for human use, especially since other safe treatments have been approved quickly. Further research is necessary to establish its role as a chemotherapy option. The paper indicates that these three patients experienced significant improvement in their cancer conditions. For more details, refer to the full paper.

Welcome to another week of media blackout. Today, we explore the potential of fenbendazole, a low-cost pet medication, as a cancer treatment. Recent case studies show three patients achieving complete remission after using fenbendazole, which works by disrupting cancer cell division. One patient, a 63-year-old man with advanced kidney cancer, saw significant tumor reduction after taking fenbendazole for ten months without side effects. Another patient, a 72-year-old man with metastatic urethral cancer, experienced dramatic lymph node shrinkage after using fenbendazole alongside other supplements. A 63-year-old woman with bladder cancer also reported complete tumor resolution after treatment. These cases suggest fenbendazole could be a safe and effective option for cancer treatment, prompting calls for further research and consideration by drug regulators. As more people share their success stories, the conversation around alternative treatments continues to grow.

A veteran physician, Dr. Karen Ruthman, was found dead after allegedly discovering a link between parasites and cancer and a suppressed cure: ivermectin. Dr. Ruthman observed that many patients with chronic illnesses and cancers had parasites. Her research indicated parasites trigger cancer, and ivermectin could treat it. Threatened after planning to reveal her findings, she died in a house fire deemed a "freak accident," though some suspect a cover-up. Experts claim the NIH is aware of the parasite-cancer connection, with studies on ivermectin and cancer. Some researchers claim cancer tumors resemble parasite egg sacs. Big Pharma profits from chronic disease and suppresses cures. Ivermectin, smeared during the COVID-19 pandemic, is a safe, Nobel Prize-winning drug that threatens their profits. Pfizer invested heavily in cancer treatments as mRNA vaccines, potentially linked to "turbo cancers," were rolled out. Experts suggest cancer is linked to parasites, mold, toxic metals, and viruses. The media allegedly altered footage to discredit ivermectin. Federal law prohibits emergency use authorization for vaccines if an existing effective treatment exists, so ivermectin had to be discredited to protect the vaccine enterprise. The World Economic Forum has warned of new injectables for various ailments, including cancers potentially caused by mRNA injections.

Fenbezodizole, a potential miracle drug for cancer, has at least 12 proven anti-cancer mechanisms of action. It is speculated that big pharma fears this drug due to its low cost. There is hope that Flint, who is mentioned in the conversation, will be interested in examining it. The drug disrupts microtubule polymerization, induces cell cycle arrest, blocks glucose transport, increases tumor suppressor levels, inhibits cancer cell viability and migration, induces autophagy, apoptosis, and necrosis, and inhibits angiogenesis and drug resistance. A similar drug, menbendazole, is already approved by the FDA and in clinical trials for brain and colon cancers. The lack of clinical trials for Fenbezodizole may be due to its low cost and effectiveness. Big pharma's lack of interest in it is seen as preventing people from accessing potentially beneficial treatments. The conversation also touches on the idea that society is designed to make people sick, with big pharma profiting from remedies.

The speaker describes a medical situation in which cancer had spread extensively: “In my neck, my liver, my bladder, my pancreas, and in my bones from head to toe.” He notes that when small cell lung cancer metastasizes this far, the prognosis is extremely poor, stating that “Life expectancy goes below one percent.” Shortly after, he received a call from a large animal veterinarian who shared a remarkable anecdote involving cancer research at Merck Animal Health on the veterinary medicine side. The veterinarian explained that a scientist working there had been implanting cancer in mice for research, and as a result her entire mouse population developed intestinal parasites. According to the story, the scientist administered fenbendazole, the drug commonly used to treat parasites in animals. Remarkably, not only did the drug save the mice from dying of intestinal parasites, but weeks later it appeared to cure the mice of cancer as well. The speaker recounts this as a concise answer to the question at hand about possible treatments. Motivated by this anecdote, the speaker began taking fenbendazole himself, starting the day after receiving the veterinarian’s account. He reports that “three and a half months later” he was all clear of cancer. In summary, the speaker connects a dire prognosis for widespread metastasized cancer with an anecdotal account from a large animal veterinary context: fenbendazole, used for parasitic infections in animals, purportedly cured cancer in mice in that story, and the speaker credits starting fenbendazole with achieving an all-clear status several months later.

Fenbendazole is described as more than just a dog dewormer, comparing that description to saying water is only for lawns. It works on various animals, impacting cestodes, nematodes, flukes, and protozoa like giardia. Fenbendazole isn't approved for human use because research is done on animals, while its cousins, mebendazole and albendazole, are researched on humans. Joe Tippins, diagnosed with small cell lung cancer, was sent home with hospice after chemotherapy led to metastasis. Following a vet's advice, he took fenbendazole, and within three months, his scans were clear. Fenbendazole binds to microtubules, preventing mitosis and causing apoptosis, similar to taxanes and vinca alkaloids. It arrests cells, upregulates tumor suppressor genes like p53 and p21, and is similar to metformin in glucose control. It inhibits hexokinase two, which is upregulated in cancers to increase glucose uptake. It also helps the immune system recognize tumors and reverses tumor-associated macrophages.

Chemotherapy is claimed to be a hoax and scam by big pharma to profit from suffering people. It allegedly prolongs life by only two to three months and may reduce life expectancy for some cancers like gastric cancer. Chemotherapy is also said to help cancer spread and activate cancer stem cells. Chemotherapy drugs can cost patients over $100,000 a year, leading to financial problems for 50-60% of patients. Ivermectin combined with mebendazole or fenbendazole is suggested as a potentially effective first-line therapy for cancer. Testing over-the-counter medications and cheap prescriptions is recommended as well.

Ivermectin, a Nobel Prize-winning anti-parasitic drug, has been vilified. Merck, who held the patent until 1996, claims it doesn't work for COVID-19. However, Merck has a 50/50 partnership with Moderna on mRNA cancer vaccines. Because Merck will make billions on mRNA cancer vaccines, they have no interest in investigating ivermectin for cancer. There is evidence that high-dose ivermectin is effective in treating many types of cancers.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like ivermectin, fenbendazole, and methylene blue, which was originally a textile dye but is now found to have significant effects on mitochondria. It's surprising how many effective treatments are overlooked or demonized, often due to profit motives. Many beneficial substances, such as vitamin D, K2, magnesium, zinc, and quercetin, are not promoted because they lack patent protection and cannot be controlled by pharmaceutical companies.

The speaker focuses on treating stage four cancer patients, often with late diagnoses. They use ivermectin combined with fenbendazole or mebendazole, both antiparasitics, even in early-stage breast cancer cases before surgery. The speaker claims that stage four cancers, including pancreatic, ovarian, and melanoma, have responded, with some patients becoming cancer-free. Tumors reportedly shrink significantly within months when patients take ivermectin and mebendazole before surgery. The speaker notes that ivermectin and fenbendazole are inexpensive, off-patent drugs, but customs in British Columbia and Mississauga are allegedly confiscating packages. A published paper supports the use of ivermectin and fenbendazole in cancer treatment. The speaker treated a friend of Mel Gibson, who then shared the story on Joe Rogan's podcast. Ivermectin is described as a chemo and radio sensitizer. The speaker faced backlash from a pancreatic cancer support group for sharing a patient's story. The speaker claims to have patients in hospice who are now cancer-free and one patient who was offered medical assistance in dying but is now cancer-free. The speaker recounts a case where a patient with terminal melanoma and liver failure stabilized and improved with ivermectin and fenbendazole. Oncologists are portrayed as limited to expensive, profitable treatments.

Speaker 0: We also know that certain parasite medications are very effective, can be very effective in targeting glutamine. And Benzol, Fenbendazole, we're working on that right now. Why would a parasite medication be effective in killing cancer? Because the parasite and the cancer cell use a common metabolic pathway, the glutaminolysis pathway, which is a substrate level phosphorylation in the mitochondria that we just published with Derek's big paper.

Fenbendazole, a potential cancer drug, has at least 12 proven anti-cancer mechanisms. It disrupts microtubule polymerization, induces cell cycle arrest, blocks glucose transport, increases tumor suppressor levels, inhibits cancer cell viability and migration, induces apoptosis and autophagy, inhibits angiogenesis and drug resistance, and sensitizes cells to chemo and radiation therapy. Mebendazole, a similar drug, is already in clinical trials for brain and colon cancers. However, there are no clinical trials for Fenbendazole, possibly because it is cheap, safe, and effective. Big pharma may not see a profit in it. This raises concerns about withholding information and preventing people from using potentially beneficial treatments. The current society seems to promote sickness, allowing big pharma to profit from remedies.

A nurse's mother initially hesitated to take Fenbendazole for her cancer, dismissing it as a dog dewormer. However, after months of persuasion, she started the treatment and experienced remarkable results. The golf ball-sized tumors in her brain, lung, liver, and kidneys disappeared. The new doctor, upon learning about the Fenbendazole, refused to treat her if she continued taking it. Sadly, she stopped the treatment and passed away three months later. A tumor in her brain grew rapidly after she stopped taking Fenbendazole. The speaker believes that Fenbendazole is effective for cancer treatment and recommends it for others.

A scientist at Merck Animal Health implanted cancer in mice for research. The mice also developed intestinal parasites, so she gave them Fenbendazole, a drug used to kill parasites. Surprisingly, the mice were cured of cancer. Inspired by this, a man with stage 4 glioblastoma started taking Fenbendazole, a dog dewormer, and mixed it with yogurt or smoothies. He bought it online without a prescription. He also added curcumin, CBD oil, and vitamin E to his regimen. This unconventional treatment is now known as the Joe Tippen's protocol.